V CompBrief BY VELARION

Independent Director · HALOZYME THERAPEUTICS, INC. (HALO)

Chair, Audit Committee

Barbara Duncan director compensation at Halozyme (FY2025): $490K

Fiscal year 2025 director compensation for Barbara Duncan at HALOZYME THERAPEUTICS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 23, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Barbara Duncan’s full pay file as a PDF — free

More than this page: up to 10 years of Barbara’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Barbara Duncan and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

HALOZYME THERAPEUTICS Director Compensation Table · all 2 fiscal years held
In US dollars, as HALOZYME THERAPEUTICS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$90,000$250,025$150,014$0$490,039
FY2022—————

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HALOZYME THERAPEUTICS, INC. DEF 14A filed March 23, 2026, accession 0001159036-26-000041, and prior-year filings. Open the filing on EDGAR.

How this page was built: the HALOZYME THERAPEUTICS, INC. filed document, accession 0001159036-26-000041. Every figure is read from that document and cited to the page and table it appears in. Filed March 23, 2026.

Get the HALOZYME THERAPEUTICS Board Governance Report

$490,039 Barbara Duncan, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of March 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

HALOZYME THERAPEUTICS pays directors a $50,000 cash retainer and $400,000 in RSUs and Options.

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Compensation

The rest of the HALOZYME THERAPEUTICS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Bernadette ConnaughtonIndependent Director$470,039
Helen I. TorleyDirector—
James LangIndependent Director$3,668
Jeffrey W. HendersonChair of the Board$540,039
Mahesh KrishnanIndependent Director$461,715
Matthew L. PosardIndependent Director$475,039
Moni MiyashitaIndependent Director$455,039

The full HALOZYME THERAPEUTICS compensation record

free company brief
HALOZYME THERAPEUTICS, INC. (HALO) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within HALOZYME THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the HALOZYME THERAPEUTICS proxy · each links to its own free brief

Order HALO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report